Hydropothecary (CVE:THCX) Stock Price Up 6.6% – Still a Buy?

Shares of The Hydropothecary Corporation (CVE:THCX – Get Free Report) traded up 6.6% during mid-day trading on Wednesday. The company traded as high as C$5.37 and last traded at C$5.30. 5,381,444 shares changed hands during trading, an increase of 129% from the average session volume of 2,350,245 shares. The stock had previously closed at C$4.97.

Hydropothecary Stock Performance

The business has a 50 day moving average of C$5.30 and a 200-day moving average of C$5.30.

About Hydropothecary

(Get Free Report)

The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.

Recommended Stories

• Five stocks we like better than Hydropothecary
• Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
• The Invisible AI Backbone: Corning’s AI Fiber Play
• Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
• Why Tesla’s Upside Is About More Than a SpaceX Merger

Receive News & Ratings for Hydropothecary Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydropothecary and related companies with MarketBeat.com's FREE daily email newsletter.